Kura Oncology stockKURA
Kura Oncology trades at $6.80, 51.1% below its 52-week high (Aug 25, 2026). The price is below its 50- and 200-day averages, a downtrend. −34.6% year to date, −31.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 10, 2026.
Ratings, candles, signals and the screener for KURA — after you log in
Open the terminalFrequently asked questions about Kura Oncology
What is the Kura Oncology stock price?
At the close on Nov 5, 2026: $6.80 (−10.64% on the day). 52-week high: $13.90 on Aug 25, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Kura Oncology report earnings?
The next quarterly report is on Nov 10, 2026. Last quarter, earnings per share changed −3% year over year, revenue +37%.
Does Kura Oncology pay dividends?
No, Kura Oncology does not pay dividends.
Where does Kura Oncology trade and how to buy it?
Ticker KURA, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Kura Oncology now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for KURA are in the terminal after you log in.